Aplastic anemia

Last updated: September 12, 2024

Aplastic anemia

Watch later

Watch later

Complications during pregnancy: Pathology review
Essential thrombocythemia (NORD)
Nucleotide metabolism
Gout
Antigout medications
Microcytic anemia: Pathology review
Macrocytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Anemia of chronic disease
Intrinsic hemolytic normocytic anemia: Pathology review
T-cell development
Immunodeficiencies: Clinical
Non-Hodgkin lymphoma
Plasma cell disorders: Pathology review
Complement system
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Selective immunoglobulin A deficiency
X-linked agammaglobulinemia
Hyper IgM syndrome
DiGeorge syndrome
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Severe combined immunodeficiency
Ataxia-telangiectasia
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chronic granulomatous disease
Chediak-Higashi syndrome
Herpes simplex virus
Varicella zoster virus
Epstein-Barr virus (Infectious mononucleosis)
Guillain-Barre syndrome
Cytomegalovirus
Cytomegalovirus infection after transplant (NORD)
Congenital cytomegalovirus (NORD)
MHC class I and MHC class II molecules
Leukemias: Pathology review
Leukemia: Clinical
Thrombotic thrombocytopenic purpura
Immune thrombocytopenia
Thrombocytopenia: Clinical
Platelet disorders: Pathology review
Blood products and transfusion: Clinical
Heparin-induced thrombocytopenia
Myeloproliferative disorders: Pathology review
Myeloproliferative neoplasms: Clinical
Myelofibrosis (NORD)
Aplastic anemia
Sideroblastic anemia
Fanconi anemia
Hodgkin lymphoma
Lymphoma: Clinical
Lymphomas: Pathology review
Monoclonal gammopathy of undetermined significance
Plasma cell disorders: Clinical
Multiple myeloma
Waldenstrom macroglobulinemia
Oncogenes and tumor suppressor genes
Vaccinations
Vaccinations: Clinical
Renal system anatomy and physiology
Development of the renal system
Action potentials in myocytes
Calcium channel blockers

Transcript

Watch video only

Aplastic anemia is a pancytopenia, meaning all blood cell lines are decreased - so the term aplastic anemia, which just refers to low red blood cell count, is actually a misnomer.

So with aplastic anemia, there’s actually anemia, as well as leukocytopenia, or low white blood cells, as well as thrombocytopenia, or low platelet levels.

This condition takes many forms, ranging from mild to severe depending on the cause.

Now, blood cells are produced in the bones of the body, mainly in the bones of the pelvis, ribs and sternum, through a process called hematopoiesis.

This process starts in the bone marrow, the innermost portion of bone, where the hematopoietic stem cells reside.

These serve as progenitor cells for all the different cell types found in the blood.

First, hematopoietic stem cells, also called hemocytoblasts, can become lymphoid progenitors or myeloid progenitors.

The lymphoid progenitors can develop into lymphoblasts, which can then differentiate into some white blood cells like T-lymphocytes, B-lymphocytes, or natural killer cells.

The myeloid progenitors can differentiate into erythrocytes, or red blood cells, megakaryocytes, which eventually give rise to platelets, or myeloblasts, which can then become other white blood cells like monocytes, neutrophils, basophils, and eosinophils.

The most common cause of aplastic anemia is autoimmune destruction of hematopoietic stem cells.

The details of this mechanism are not fully understood, but research shows that there are alterations in the immunologic appearance of hematopoietic stem cells because of genetic disorders, or after exposure to environmental agents, like radiation or toxins.

This means that the hematopoietic stem cells start expressing non-self antigens and the immune system subsequently targets them for destruction.

As the immune system destroys hematopoietic stem cells a whole host of complications arise.

Due to the low red blood cell count tissues cannot properly oxygenate so the heart pumps harder to circulate the red blood cells leading to chest pain and shortness of breath.

Low platelet counts lead to an increased risk of bleeding from the most minor injuries and in mucosal areas. Low white blood cells counts lead to the body’s inability to fight off common infections that can lead to sepsis.

Now, there are many causes of aplastic anemia, but the disease is most often idiopathic, or without an identifiable cause.

Definable causes of aplastic anemia include radiation and toxins like insecticides or industrial agents that contain benzene.

Drugs that may cause aplastic anemia include chemotherapeutic agents, anti-seizure medications, antiinflammatory medications like indomethacin, antithyroid medications like propylthiouracil and methimazole, and antibiotics like chloramphenicol and sulfonamides.

Key Takeaways

Aplastic anemia is a rare blood disorder caused by bone marrow failure to produce new blood cells. Even though it's referred to as aplastic anemia, it typically presents with pancytopenia, meaning that all three major blood cell lines - the red blood cells, white blood cells, and platelets are affected.

People with aplastic anemia may experience fatigue, shortness of breath, ecchymoses and mucosal bleeding, and frequent infections pallor Aplastic anemia can be caused by a variety of factors, including exposure to radiation or chemotherapy, viral infections, and autoimmune disorders.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  3. "Current concepts in the pathophysiology and treatment of aplastic anemia" Hematology (2013)
  4. "Aplastic anaemia" Hematology (2013)
  5. "Aplastic Anemia" New England Journal of Medicine (2018)
  6. "Harrison's Principles of Internal Medicine" McGraw-Hill (2004)
  7. "The complex pathophysiology of acquired aplastic anaemia" Clinical & Experimental Immunology (2015)